Literature DB >> 4638419

Treatment of severe bacteroides infections with parenteral clindamycin.

E V Haldane, C E Van Rooyen.   

Abstract

Clindamycin, by intravenous or intramuscular administration, was used in the treatment of 18 patients seriously ill with infections due to bacteroides organisms. In 17 cases there was a rapid favourable clinical response to treatment. No serious toxic effects were observed. This study appears to confirm previous in vitro evidence that clindamycin is presently the antibiotic of choice for such infections.

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4638419      PMCID： PMC1941080     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


  9 in total

1.  The susceptibility of Bacteroides fragilis to 24 antibiotics.

Authors:  J W Kislak
Journal:  J Infect Dis       Date:  1972-03       Impact factor: 5.226

2.  Clinical and bacteriological studies with clindamycin.

Authors:  A M Geddes; F A Bridgwater; D N Williams; J Oon; G J Grimshaw
Journal:  Br Med J       Date:  1970-06-20

3.  Bactericidal activity of five antimicrobial agents against Bacteroides fragilis.

Authors:  L J Nastro; S M Finegold
Journal:  J Infect Dis       Date:  1972-07       Impact factor: 5.226

4.  Bacteroides pneumonias. Characteristics of cases with empyema.

Authors:  J R Tillotson; A M Lerner
Journal:  Ann Intern Med       Date:  1968-02       Impact factor: 25.391

5.  Bacteroides bacteremia. Experience in a hospital for neoplastic diseases.

Authors:  M F Kagnoff; D Armstrong; A Blevins
Journal:  Cancer       Date:  1972-01       Impact factor: 6.860

6.  In vitro antimicrobial susceptibility of anaerobic bacteria isolated from clinical specimens.

Authors:  W J Martin; M Gardner; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1972-02       Impact factor: 5.191

7.  The effect of carbon dioxide on the sensitivity of Bacteroides fragilis to certain antibiotics in vitro.

Authors:  H R Ingham; J B Selkon; A A Codd; J H Hale
Journal:  J Clin Pathol       Date:  1970-04       Impact factor: 3.411

8.  Lincomycins in the treatment of bacteroides infections.

Authors:  O Tracy; A M Gordon; F Moran; W C Love; P McKenzie
Journal:  Br Med J       Date:  1972-01-29

9.  A study in vitro of the sensitivity to antibiotics of Bacteroides fragilis.

Authors:  H R Ingham; J B Selkon; A A Codd; J H Hale
Journal:  J Clin Pathol       Date:  1968-07       Impact factor: 3.411
  9 in total
  10 in total

1.  Chemotherapy of an experimental Fusobacterium (Sphaerophorus) necrophorum infection in mice.

Authors:  T D Wilkins; L D Smith
Journal:  Antimicrob Agents Chemother       Date:  1974-06       Impact factor: 5.191

2.  Treatment of Bacteroides infection with clindamycin-2-phosphate.

Authors:  P C Dickinson; P Saphyakhajon
Journal:  Can Med Assoc J       Date:  1974-11-02       Impact factor: 8.262

3.  Clindamycin phosphate in severe infections mainly caused by Bacteroides fragilis: clinical and microbiological evaluation.

Authors:  E Schoutens; D Van Beers; E Yourassowsky
Journal:  Infection       Date:  1974       Impact factor: 3.553

Review 4.  Infectious diseases: annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1974-08       Impact factor: 2.401

5.  Streptococcus bovis endocarditis.

Authors:  E V Haldane; J H Haldane; G Digout; A West; C E van Rooyen
Journal:  Can Med Assoc J       Date:  1974-10-05       Impact factor: 8.262

6.  Antimicrobial susceptibilities of anaerobic bacteria: recent clinical isolates.

Authors:  J L Staneck; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

7.  Speed of bactericidal action of penicillin G, ampicillin, and carbenicillin on Bacteroides fragilis.

Authors:  E Schoutens; E Yourassowsky
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

8.  Prospective, randomized, double-blind comparison of metronidazole and tobramycin with clindamycin and tobramycin in the treatment of intra-abdominal sepsis.

Authors:  J A Smith; A G Skidmore; A D Forward; A M Clarke; E Sutherland
Journal:  Ann Surg       Date:  1980-08       Impact factor: 12.969

9.  Clindamycin plus gentamicin as expectant therapy for presumed mixed infections.

Authors:  A W Chow; J K Ota; L B Guze
Journal:  Can Med Assoc J       Date:  1976-12-18       Impact factor: 8.262

10.  Treatment of anaerobic bacterial infections with clindamycin-2-phosphate.

Authors:  M E Levison; J L Bran; K Ries
Journal:  Antimicrob Agents Chemother       Date:  1974-03       Impact factor: 5.191
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.